StonvexLoading…
StonvexStonvexStonvexCore line items from HCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $242.88M | $900.95M | $216.35M | $221.92M |
Operating Income | $115.38M | $429.33M | $90.60M | $94.39M |
Net Income | $73.41M | $299.00M | $201.35M | $135.84M |
EPS (Diluted) | $5.45 | $22.72 | $4.90 | $5.18 |
Total Assets | $2.61B | $2.53B | $2.35B | $2.35B |
Total Liabilities | $1.43B | $1.41B | $1.49B | $1.57B |
Cash & Equivalents | $1.01B | $1.21B | $987.93M | $947.17M |
Free Cash Flow OCF − CapEx | $148.48M | $440.82M | $330.63M | $304.75M |
Shares Outstanding | 12.90M | 12.99M | 12.96M | 12.96M |